Zinc phthalocyanine

CAS No. 14320-04-8

Zinc phthalocyanine( ZnPc )

Catalog No. M20539 CAS No. 14320-04-8

Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 26 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zinc phthalocyanine
  • Note
    Research use only, not for human use.
  • Brief Description
    Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).
  • Description
    Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZnPc
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14320-04-8
  • Formula Weight
    577.9
  • Molecular Formula
    C32H16N8Zn
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMF : 2.7 mg/mL (4.67 mM)
  • SMILES
    N=4c2c1ccccc1c3N=C%10N=C(N=C8N([Zn]n23)C(=NC5=NC=4c6ccccc56)c7ccccc78)c9ccccc9%10
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rel-TREM2 agonist-2

    rel-5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2R,4S)-tetrahydro-2-(1-methyl-1H-pyrazol-4-yl)-2H-pyran-4-yl]pyrido[3,4-b] The EC50 value of pyrazine against TREM2 was ≤ 0.05 μM and the E.max value was > 250 μM.

  • MLS000545091

    MLS000545091 is a potent and selective human epithelial 15-lipoxygenase-2 (mixed-type) inhibitor.

  • BDA 366

    BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.